World’s No. 3 Container Carrier Warns Against Price War
CMA CGM SA, the world’s No. 3 container carrier, urged the industry to avoid a price war as
2023-11-11 00:54
Australia’s Housing Crunch Lures More Private Credit Lenders
Private credit funds, backed by some major global investors, are venturing where Australian banks increasingly fear to tread:
2023-11-10 11:47
Markets Price an End to Interest-Rate Hikes Across the World
Rates traders are betting that the steepest global tightening cycle in a generation is over and that monetary
2023-11-09 17:45
Australia’s Top Three Inflation Drivers Beyond RBA’s Control
Australian inflation is being driven by climate change, geopolitical shocks and government policies — factors typically beyond the
2023-11-01 07:49
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 07:17
Surprisingly Strong Australia Retail Sales Cement Hike Bets
Australian retail sales surpassed expectations in September, an outcome that will likely boost the central bank’s confidence that
2023-10-30 11:23
Strong Dollar Keeps Rate Hikes on Table for Asian Central Banks
Asian central banks are seen to raise interest rates over the next six months, with a stronger dollar
2023-10-30 10:27
Ueda Faces Market Fallout Risk as BOJ Mulls Yields, Prices, Yen
The Bank of Japan’s Kazuo Ueda is in a tight spot. If he stands pat on policy this
2023-10-30 08:26
Philippines Announces Quarter-Point Rate Hike in Off-Cycle Move
The Philippine central bank resumed tightening monetary policy as it lifted its benchmark interest rate by 25 basis
2023-10-26 15:51
Taiwan ex-colonel gets 20 years for spying for China
The retired officer was convicted of recruiting active-duty officers to give China military secrets.
2023-10-26 14:45
China’s Economy Is in Search of More Stable Footing
China’s economy isn’t yet on secure footing, as recent green shoots have been offset by lingering fears about
2023-10-15 18:48
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:20